Neuroendocrine Cancer Foundation

🦓November 10 | World NET Cancer Day
Think Zebras
Learn. Share. Make a Difference.

Today, the Neuroendocrine Cancer Foundation (NCF) joins the global community in raising awareness, honoring patients and caregivers, and supporting everyone affected by neuroendocrine cancer.

Neuroendocrine cancer is complex, often misunderstood, and can be difficult to diagnose. While neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs) are distinct diagnoses, every patient deserves access to education, specialized care, and compassionate support.

📢 Explore our awareness page: Find facts, educational resources, and ways to help spread awareness. ncf.net/awareness

📚New from NCF  — Dedicated NEC Resources: Information to help patients and caregivers understand an NEC diagnosis, explore treatment options, and find support. ncf.net/nec

On World NET Cancer Day, we honor those living with neuroendocrine cancer, remember those we've lost, and recognize the families, caregivers, healthcare professionals, and advocates who make a difference every day.

Awareness starts with a conversation. Help us spread the word.

#WorldNETCancerDay #NETCancerDay #ThinkZebra #NeuroendocrineCancer #NeuroendocrineTumors #NEC #NETAwareness #NCFCancer #LetsTalkAboutNETs

🦓 Together in Awareness. Stronger Through Connection.

Join the Neuroendocrine Cancer Foundation (NCF) for the 2026 NET Cancer Day Symposium in Las Vegas!

In honor of World NET Cancer Day, we're bringing patients, caregivers, families, and leading medical experts together for a meaningful day of education, empowerment, and community.

🗓️ Sunday, November 8, 2026
⏲️ 8:00 AM – 3:00 PM
📍 JW Marriott Las Vegas Resort & Spa, Las Vegas, NV

What to Expect:
- Expert discussions on neuroendocrine cancer diagnosis, treatments, and emerging therapies
- Interactive Q&A sessions with leading specialists
- Opportunities to connect with patients, caregivers, and healthcare professionals
- Complimentary breakfast, lunch, and a dessert reception

Attendance is FREE for patients and family members!
Whether you're newly diagnosed, navigating treatment, or supporting someone you love, this event offers valuable knowledge, meaningful connections, and a community that understands.

Register today: ncf.net/events/ncd2026

#NETCancerDay #NeuroendocrineCancer #NETcancerawareness #worldnetcancerday #ncfcancer #cancercommunity #lasvegas

📌 Join us for an upcoming virtual webinar: “Liver NETs: Understanding Liver-Directed Therapies and PRRT”

🗓️ Thursday, October 29, 2026
⏲️ 4:00–5:30 PM Pacific
💻 Virtual Event

Join Gabriel Fine, M.D., a diagnostic radiologist and nuclear medicine specialist at City of Hope Cancer Center, for an overview of liver-directed therapies and peptide receptor radionuclide therapy (PRRT). The discussion will explore how treatment decisions are made, when different approaches may be considered, and how these therapies can fit into an overall NET treatment plan.

There will also be an opportunity to submit general questions for Dr. Fine to address during the live Q&A.

➡️ Learn more and register: ncf.net/events/oct2026
#NeuroendocrineCancer #NETcancer #neuroendocrinetumors #livernets #prrt #CancerEducation #PatientEducation #CancerSupport #netcommunity

Join the Neuroendocrine Cancer Foundation for “Practical Tips in Managing Your Neuroendocrine Cancer Care” today from 10:00–11:30 AM Pacific.

Taymeyah Al-Toubah and Tiffany Romershausen, MPH, MSN, AGPCNP-C, of Moffitt Cancer Center share important insights to help you spearhead your medical team and confidently navigate your healthcare. Gain practical logistics for managing the ongoing cycle of scans, lab work, and "ologist" appointments. Discover well-informed, real-world suggestions on finding and building strong partnerships with your providers and specialists. We hope this discussion empowers you to effectively and efficiently coordinate your care.

Topics include:
✨ Coordinating NET care
✨ Working with NET specialists
✨ Preparing for oncology appointments
✨ Patient advocacy and second opinions
✨ Scans and symptom management
✨ Communicating effectively with your medical team

💻 This is a virtual event.

Watch it here: ncf.net/events/sep2026

#NeuroendocrineCancer #NETcancer #NeuroendocrineTumor #cancersupport #PatientAdvocacy #cancercaregiver #netcommunity #ncfcancer

📣 New FDA Approval for the Neuroendocrine Cancer Community

The U.S. Food and Drug Administration (FDA) has approved BRAVNETSA™ (lutetium Lu-177 dotatate) injection for the treatment of adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (SSTR-positive GEP-NETs), including foregut, midgut, and hindgut NETs.

BRAVNETSA offers another treatment option for patients and families navigating neuroendocrine tumors.

Please note: BRAVNETSA is not currently commercially available. Additional information about availability is expected in the future.

Learn more and review the full prescribing and safety information:
lantheus.com/bravnetsa-pres…

Availability updates:
bravnetsahcp.com

#neuroendocrinetumors #NETcancer #gepnets #nuclearmedicine #PatientAdvocacy #ncfcancer

@LantheusNews